Re-examining the role of prostate-specific antigen density in predicting outcome for clinically localized prostate cancer

By Ingenito A.C.   Ennis R.D.   Hsu I.-C.   Begg M.D.   Benson M.C.   Schiff P.B.  

Urology, Vol. 50, Iss. 1, 1997-07 ,pp. : 73-78

Elsevier

Access to resources Recommend Favorite

Role of prostate-specific antigen velocity in prediction of final pathologic stage in men with localized prostate cancer

By Thiel R.   Pearson J.D.   Epstein J.I.   Walsh P.C.   Carter H.B.  

Urology, Vol. 49, Iss. 5, 1997-05 ,pp. : 716-720

Elsevier

Access to resources Recommend Favorite

Free, complexed, and total serum prostate-specific antigen concentrations and their proportions in predicting stage, grade, and deoxyribonucleic acid ploidy in patients with adenocarcinoma of the prostate

By Lerner S.E.   Jacobsen S.J.   Lilja H.   Bergstralh E.J.   Ransom J.   Klee G.G.   Piironen T.   Blute M.L.   Lieber M.M.   Zincke H.   Pettersson K.   Peterson D.   Oesterling J.E.  

Urology, Vol. 48, Iss. 2, 1996-08 ,pp. : 240-248

Elsevier

Access to resources Recommend Favorite

Free-to-total prostate-specific antigen ratio as a predictor of non-organ-confined prostate cancer (stage pT3)

By Aus Gunnar   Becker Charlotte   Lilja Hans   Khatami Ali   Pihl Carl-Gustaf   Hugosson Jonas  

Scandinavian Journal of Urology and Nephrology, Vol. 37, Iss. 6, 2003-11 ,pp. : 466-470

Informa Healthcare

Access to resources Recommend Favorite

Serum prostate-specific antigen for prostate cancer early detection: total, free, age- stratified, or complexed?

By Carroll P.R.  

Urology, Vol. 57, Iss. 4, 2001-04 ,pp. : 591-593

Elsevier

Access to resources Recommend Favorite